Financial Ratios Bolt Biotherapeutics, Inc.

Equities

BOLT

US0977022039

Biotechnology & Medical Research

Delayed Nasdaq Other stock markets 20:25:38 13/05/2026 BST			5-day change	1st Jan Change
4.790 ^USD	+0.21%		+2.83%	-13.68%

05-12	Bolt Biotherapeutics reports first quarter 2026 financial results	RE
05-12	Bolt Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

36f3f4407a.qSkXjzc4_-qz7fstNfyeeNVgyRy4guLGU3PtAGVgESs.4VhG5hpwtYiDnKFbQ7L0M78_rmj6tqGkGzanTlQxWRzcYkjBVW7Mi_Wgvg

Published financial data: BOLT BIOTHERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.26M	5.73M	7.88M	7.69M	7.7M
Total Revenues	1.26M	5.73M	7.88M	7.69M	7.7M
Cost of Goods Sold, Total	75.66M	73.12M	61.54M	57.47M	28.53M
Gross Profit	-74.4M	-67.39M	-53.67M	-49.78M	-20.84M
Selling General & Admin Expenses, Total	18.39M	22.93M	22.53M	18.46M	13.8M
Other Operating Expenses, Total	18.39M	22.93M	22.53M	18.46M	13.8M
Operating Income	-92.79M	-90.32M	-76.2M	-68.24M	-34.63M
Interest And Investment Income	281K	2.22M	7M	5.26M	2.5M
Net Interest Expenses	281K	2.22M	7M	5.26M	2.5M
Other Non Operating Income (Expenses)	-6.08M	-	-	-	241K
EBT, Excl. Unusual Items	-98.59M	-88.1M	-69.2M	-62.98M	-31.9M
Restructuring Charges	-	-	-	-3.34M	-1.48M
Asset Writedown	-	-	-	-1.47M	-
Other Unusual Items	-	-	-	4.68M	-
EBT, Incl. Unusual Items	-98.59M	-88.1M	-69.2M	-63.12M	-33.38M
Earnings From Continuing Operations	-98.59M	-88.1M	-69.2M	-63.12M	-33.38M
Net Income to Company	-98.59M	-88.1M	-69.2M	-63.12M	-33.38M
Net Income - (IS)	-98.59M	-88.1M	-69.2M	-63.12M	-33.38M
Net Income to Common Incl Extra Items	-98.59M	-88.1M	-69.2M	-63.12M	-33.38M
Net Income to Common Excl. Extra Items	-98.59M	-88.1M	-69.2M	-63.12M	-33.38M
Per Share Items
Net EPS - Basic	-59.4	-47.16	-36.6	-33.06	-17.85
Basic EPS - Continuing Operations	-59.4	-47.16	-36.6	-33.06	-17.85
Basic Weighted Average Shares Outstanding	1.66M	1.87M	1.89M	1.91M	1.87M
Net EPS - Diluted	-59.4	-47.16	-36.6	-33.06	-17.85
Diluted EPS - Continuing Operations	-59.4	-47.16	-36.6	-33.06	-17.85
Diluted Weighted Average Shares Outstanding	1.66M	1.87M	1.89M	1.91M	1.87M
Normalized Basic EPS	-37.12	-29.48	-22.88	-20.62	-10.66
Normalized Diluted EPS	-37.12	-29.48	-22.88	-20.62	-10.66
Supplemental Items
EBITDA	-91.6M	-88.66M	-74.34M	-66.46M	-33.34M
EBITA	-92.79M	-90.32M	-76.2M	-68.24M	-34.63M
EBIT	-92.79M	-90.32M	-76.2M	-68.24M	-34.63M
EBITDAR	-88.55M	-85.11M	-70.66M	-62.33M	-30.74M
Normalized Net Income	-61.62M	-55.06M	-43.25M	-39.36M	-19.94M
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	18.39M	22.93M	22.53M	18.46M	13.8M
Research And Development Expense From Footnotes	75.66M	73.12M	61.54M	57.47M	28.53M
Net Rental Expense, Total	3.04M	3.55M	3.68M	4.12M	2.6M
Stock-Based Comp., COGS (Total)	4.46M	4.11M	3.7M	3.15M	1.16M
Stock-Based Comp., G&A Exp. (Total)	4.04M	5.47M	5.52M	4.26M	1.62M
Total Stock-Based Compensation	8.5M	9.58M	9.22M	7.41M	2.78M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	27.38M	9.24M	10.81M	7.2M	11.7M
Short Term Investments	159M	160M	91.38M	40.12M	15.8M
Total Cash And Short Term Investments	186M	169M	102M	47.32M	27.5M
Other Receivables	200K	800K	1.3M	808K	973K
Total Receivables	200K	800K	1.3M	808K	973K
Prepaid Expenses	2.74M	3.06M	2.04M	1.84M	1.41M
Restricted Cash	-	-	-	784K	200K
Other Current Assets, Total	-	-	178K	55K	175K
Total Current Assets	189M	173M	106M	50.81M	30.26M
Gross Property Plant And Equipment	32.85M	32.44M	29.83M	32.17M	27.86M
Accumulated Depreciation	-2.24M	-3.92M	-5.75M	-7.28M	-7.39M
Net Property Plant And Equipment	30.6M	28.52M	24.08M	24.9M	20.48M
Long-term Investments	85.35M	23.94M	26.41M	22.88M	4.34M
Deferred Charges Long-Term	-	-	371K	51K	137K
Other Long-Term Assets, Total	2.61M	2.59M	3.22M	992K	1.54M
Total Assets	308M	228M	160M	99.63M	56.75M
Liabilities
Accounts Payable, Total	3.57M	3.59M	2.99M	1.51M	1.44M
Accrued Expenses, Total	12.38M	15.14M	12.49M	8.34M	2.97M
Current Portion of Leases	2.5M	2.39M	2.78M	2.25M	2.83M
Unearned Revenue Current, Total	2.87M	1.99M	2.2M	3.02M	449K
Other Current Liabilities	-	-	-	739K	744K
Total Current Liabilities	21.33M	23.12M	20.46M	15.86M	8.44M
Long-Term Leases	21.85M	20.22M	17.44M	22.96M	20.13M
Unearned Revenue Non Current	14.21M	12.92M	9.11M	3.62M	1.54M
Other Non Current Liabilities	210K	42K	43K	-	132K
Total Liabilities	57.6M	56.3M	47.04M	42.43M	30.24M
Preferred Stock Convertible	-	-	-	-	-
Preferred Stock - Others	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	-	-	1K	-	-
Additional Paid In Capital	457M	468M	477M	485M	487M
Retained Earnings	-207M	-295M	-364M	-427M	-461M
Comprehensive Income and Other	-321K	-919K	37K	97K	-21K
Total Common Equity	250M	172M	113M	57.2M	26.5M
Total Equity	250M	172M	113M	57.2M	26.5M
Total Liabilities And Equity	308M	228M	160M	99.63M	56.75M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.87M	1.89M	1.91M	1.92M	1.92M
ECS Total Common Shares Outstanding	1.87M	1.89M	1.91M	1.92M	1.92M
Book Value / Share	133.75	90.75	59.16	29.84	13.8
Tangible Book Value	250M	172M	113M	57.2M	26.5M
Tangible Book Value Per Share	133.75	90.75	59.16	29.84	13.8
Total Debt	24.36M	22.61M	20.22M	25.21M	22.96M
Net Debt	-162M	-146M	-81.97M	-22.11M	-4.55M
Debt Equivalent Oper. Leases	24.34M	28.37M	29.44M	32.98M	20.84M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	8.26M	10.1M	10.42M	10.13M	8.27M
Full Time Employees	91	94	100	52	23

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-98.59M	-88.1M	-69.2M	-63.12M	-33.38M
Depreciation & Amortization - CF	1.19M	1.67M	1.85M	1.78M	1.29M
Depreciation & Amortization, Total	1.19M	1.67M	1.85M	1.78M	1.29M
(Gain) Loss From Sale Of Asset	108K	-	-	-70K	-288K
(Gain) Loss on Sale of Investments - (CF)	2.65M	184K	-4.49M	-2.62M	-670K
Asset Writedown & Restructuring Costs	-	-	-	1.47M	-
Stock-Based Compensation (CF)	8.5M	9.58M	9.22M	7.41M	2.78M
Other Operating Activities, Total	8.56M	3.22M	2.95M	2.3M	2.53M
Change In Accounts Payable	6.68M	2.77M	-3.41M	-4.88M	-5.43M
Change in Unearned Revenues	15.57M	-2.16M	-3.61M	-4.67M	-4.64M
Change in Other Net Operating Assets	-1.74M	-3.66M	-2.84M	1.12M	-2.04M
Cash from Operations	-57.07M	-76.5M	-69.52M	-61.29M	-39.85M
Capital Expenditure	-2.34M	-1.95M	-206K	-41K	-72K
Sale of Property, Plant, and Equipment	-	-	-	148K	963K
Investment in Marketable and Equity Securities, Total	-230M	59.82M	71.24M	57.47M	43.41M
Cash from Investing	-232M	57.86M	71.04M	57.58M	44.3M
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	259M	503K	253K	108K	19K
Issuance of Preferred Stock	51.9M	-	-	-	-
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	311M	503K	253K	108K	19K
Net Change in Cash	21.84M	-18.14M	1.77M	-3.6M	4.47M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Levered Free Cash Flow	-41.99M	-46.18M	-39.47M	-37.54M	-24.9M
Unlevered Free Cash Flow	-41.99M	-46.18M	-39.47M	-37.54M	-24.9M
Change In Net Working Capital	-8.65M	-983K	2.71M	4.04M	7.26M
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-32.74	-21.08	-24.57	-32.88	-27.68
Return on Total Capital	-37.3	-24.09	-29.12	-39.6	-32.83
Return On Equity %	-71.52	-41.79	-48.69	-74.28	-79.75
Return on Common Equity	-135.83	-41.79	-48.69	-74.28	-79.75
Margin Analysis
Gross Profit Margin %	-5.9K	-1.18K	-681.39	-647.32	-270.8
SG&A Margin	1.46K	400.19	286.06	240.01	179.27
EBITDA Margin %	-7.27K	-1.55K	-943.91	-864.17	-433.29
EBITA Margin %	-7.36K	-1.58K	-967.45	-887.33	-450.07
EBIT Margin %	-7.36K	-1.58K	-967.45	-887.33	-450.07
Income From Continuing Operations Margin %	-7.82K	-1.54K	-878.58	-820.78	-433.74
Net Income Margin %	-7.82K	-1.54K	-878.58	-820.78	-433.74
Net Avail. For Common Margin %	-7.82K	-1.54K	-878.58	-820.78	-433.74
Normalized Net Income Margin	-4.89K	-961.1	-549.11	-511.87	-259.06
Levered Free Cash Flow Margin	-3.33K	-806.05	-501.09	-488.19	-323.65
Unlevered Free Cash Flow Margin	-3.33K	-806.05	-501.09	-488.19	-323.65
Asset Turnover
Asset Turnover	0.01	0.02	0.04	0.06	0.1
Fixed Assets Turnover	0.05	0.19	0.3	0.31	0.34
Short Term Liquidity
Current Ratio	8.87	7.47	5.17	3.2	3.59
Quick Ratio	8.74	7.34	5.06	3.04	3.38
Operating Cash Flow to Current Liabilities	-2.68	-3.31	-3.4	-3.87	-4.72
Average Days Payable Outstanding	12.48	17.89	19.52	14.31	18.87
Long Term Solvency
Total Debt/Equity	9.74	13.18	17.93	44.07	86.62
Total Debt / Total Capital	8.87	11.65	15.21	30.59	46.41
LT Debt/Equity	8.74	11.79	15.47	40.14	75.96
Long-Term Debt / Total Capital	7.96	10.42	13.11	27.86	40.7
Total Liabilities / Total Assets	18.72	24.71	29.44	42.59	53.29
Total Debt / EBITDA	-0.28	-0.27	-0.29	-0.4	-0.75
Net Debt / EBITDA	1.83	1.72	1.16	0.35	0.15
Total Debt / (EBITDA - Capex)	-0.27	-0.26	-0.29	-0.4	-0.75
Net Debt / (EBITDA - Capex)	1.78	1.68	1.16	0.35	0.15
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	445.45	354.68	37.48	-2.36	0.06
Gross Profit, 1 Yr. Growth %	85.4	-9.41	-20.37	-7.24	-58.14
EBITDA, 1 Yr. Growth %	88.58	-3.21	-16.14	-10.61	-49.83
EBITA, 1 Yr. Growth %	88.66	-2.66	-15.64	-10.45	-49.25
EBIT, 1 Yr. Growth %	88.66	-2.66	-15.64	-10.45	-49.25
Earnings From Cont. Operations, 1 Yr. Growth %	62.35	-10.64	-21.45	-8.79	-47.12
Net Income, 1 Yr. Growth %	62.35	-10.64	-21.45	-8.79	-47.12
Normalized Net Income, 1 Yr. Growth %	62.35	-10.64	-21.45	-8.98	-49.36
Diluted EPS Before Extra, 1 Yr. Growth %	-89.72	-20.6	-22.4	-9.67	-46.01
Net Property, Plant and Equip., 1 Yr. Growth %	87.17	-6.79	-15.59	3.4	-17.75
Total Assets, 1 Yr. Growth %	561.16	-25.97	-29.86	-37.65	-43.04
Tangible Book Value, 1 Yr. Growth %	-338.33	-31.43	-34.26	-49.27	-53.66
Common Equity, 1 Yr. Growth %	-338.33	-31.43	-34.26	-49.27	-53.66
Cash From Operations, 1 Yr. Growth %	20.63	34.06	-9.12	-11.85	-34.98
Capital Expenditures, 1 Yr. Growth %	-28.33	-16.47	-89.45	-80.1	75.61
Levered Free Cash Flow, 1 Yr. Growth %	43.73	9.97	-14.54	-4.88	-33.66
Unlevered Free Cash Flow, 1 Yr. Growth %	43.73	9.97	-14.54	-4.88	-33.66
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	142.08	398	150.02	15.86	-1.16
Gross Profit, 2 Yr. CAGR %	69.85	29.6	-15.07	-14.06	-37.69
EBITDA, 2 Yr. CAGR %	72.92	35.1	-9.91	-13.42	-33.03
EBITA, 2 Yr. CAGR %	73.09	35.52	-9.38	-13.08	-32.58
EBIT, 2 Yr. CAGR %	73.09	35.52	-9.38	-13.08	-32.58
Earnings From Cont. Operations, 2 Yr. CAGR %	79.83	20.44	-16.22	-15.36	-30.55
Net Income, 2 Yr. CAGR %	79.83	20.44	-16.22	-15.36	-30.55
Normalized Net Income, 2 Yr. CAGR %	79.83	20.44	-16.22	-15.45	-32.11
Diluted EPS Before Extra, 2 Yr. CAGR %	-55.93	-71.43	-21.5	-16.28	-30.17
Net Property, Plant and Equip., 2 Yr. CAGR %	63.01	32.09	-11.3	-6.58	-7.78
Total Assets, 2 Yr. CAGR %	152.02	121.24	-27.94	-33.87	-40.41
Tangible Book Value, 2 Yr. CAGR %	133.57	27.84	-32.86	-42.25	-51.51
Common Equity, 2 Yr. CAGR %	133.57	27.84	-32.86	-42.25	-51.51
Cash From Operations, 2 Yr. CAGR %	47.18	27.17	10.38	-10.49	-24.29
Capital Expenditures, 2 Yr. CAGR %	114.53	-22.62	-70.32	-85.51	-40.88
Levered Free Cash Flow, 2 Yr. CAGR %	63.08	25.72	-3.05	-9.84	-20.56
Unlevered Free Cash Flow, 2 Yr. CAGR %	63.08	25.72	-3.05	-9.84	-20.56
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	198.68	224.26	82.75	10.33
Gross Profit, 3 Yr. CAGR %	99.14	37.74	10.18	-12.54	-32.38
EBITDA, 3 Yr. CAGR %	100.72	42.51	15.24	-10.14	-27.82
EBITA, 3 Yr. CAGR %	99.82	42.87	15.71	-9.74	-27.35
EBIT, 3 Yr. CAGR %	99.82	42.87	15.71	-9.74	-27.35
Earnings From Cont. Operations, 3 Yr. CAGR %	104.14	42.44	4.45	-13.81	-27.64
Net Income, 3 Yr. CAGR %	104.14	42.44	4.45	-13.81	-27.64
Normalized Net Income, 3 Yr. CAGR %	104.14	42.44	4.45	-13.88	-28.73
Diluted EPS Before Extra, 3 Yr. CAGR %	-24.93	-46.38	-60.14	-17.74	-27.67
Net Property, Plant and Equip., 3 Yr. CAGR %	176.86	35.3	13.77	-6.65	-10.46
Total Assets, 3 Yr. CAGR %	168.06	67.53	50.86	-31.33	-37.08
Tangible Book Value, 3 Yr. CAGR %	150.34	55.24	2.42	-38.85	-46.34
Common Equity, 3 Yr. CAGR %	150.34	55.24	2.42	-38.85	-46.34
Cash From Operations, 3 Yr. CAGR %	79.47	42.67	13.69	2.41	-19.54
Capital Expenditures, 3 Yr. CAGR %	100.52	56.66	-60.18	-74.02	-66.72
Levered Free Cash Flow, 3 Yr. CAGR %	-	43.01	10.54	-3.67	-18.6
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	43.01	10.54	-3.67	-18.6
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	104.5	101.61
Gross Profit, 5 Yr. CAGR %	-	-	41.62	14.06	-12.28
EBITDA, 5 Yr. CAGR %	-	-	45.69	16.75	-7.25
EBITA, 5 Yr. CAGR %	-	-	45.64	17.12	-6.77
EBIT, 5 Yr. CAGR %	-	-	45.64	17.12	-6.77
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	42.96	15.67	-11.28
Net Income, 5 Yr. CAGR %	-	-	42.96	15.67	-11.28
Normalized Net Income, 5 Yr. CAGR %	-	-	42.96	15.62	-12.08
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-23.58	-35.92	-50.11
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	75.6	16.67	4.6
Total Assets, 5 Yr. CAGR %	-	-	58.5	15.51	4.04
Tangible Book Value, 5 Yr. CAGR %	-	-	47.88	4.52	-24.06
Common Equity, 5 Yr. CAGR %	-	-	47.88	4.52	-24.06
Cash From Operations, 5 Yr. CAGR %	-	-	47.76	18.4	-3.37
Capital Expenditures, 5 Yr. CAGR %	-	-	-6.61	-39.55	-53.36
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	18.91	-3.14
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	18.91	-3.14